Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 September 2021 | Story Dr Nitha Ramnath
Prof Bonang Mohale.


The executive management of the University of the Free State (UFS) and the university community extend heartfelt congratulations to Prof Bonang Mohale on his appointment as President of Business Unity South Africa (BUSA). 

“Prof Mohale’s extensive expertise and experience in leadership roles, contributions to the growth of many multinational companies, and involvement in education and the business sector, will undoubtedly strengthen the ties between various sectors and civil society, and further contribute to the stabilisation and growth of South Africa,” said Prof Francis Petersen, UFS Rector and Vice-Chancellor, in his congratulatory letter to Prof Mohale. 

BUSA’s role in influencing policy and legislative development for inclusive growth and employment, and in building an enabling environment for the creation of a vibrant, diverse, and globally competitive economy that harnesses the economic and human potential in South Africa, is well documented. This potential resides in our higher education institutions in the form of our students, future graduates, and graduates who are the building blocks for the development of South Africa. 

At a time when our country is facing a social and economic crisis, we are confident that BUSA will consider the perspectives across sectors with a view to creating partnerships, collaboration, and co-creation and further play an integral role in our higher education institutions for the benefit of our students. 

“Prof Mohale’s support to the UFS is appreciated, especially his role as Chancellor and his contribution towards our Thought-Leader and Global Citizen programmes, through which important national and global issues are addressed.
 
We wish Prof Mohale every success in his endeavours, particularly as President of BUSA,” said Prof Petersen.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept